3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
2
Cisplatin
2
Boron Neutron Capture Therapy
2
Tranexamic Acid
1
Therapeutics
1
Surgical Procedures, Operative
1
Self Care
1
Radiography, Panoramic
1
Observation
1
Neck Dissection
1
Moxibustion
1
Morphine
1
Magnesium Sulfate
1
Low-Level Light Therapy
1
Lidocaine
1
Hypnosis
1
Gels
1
Gefitinib
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Educational Status
1
DMAC2L protein, human
1
Control Groups
1
Chemoradiotherapy
1
Cetuximab
1
Celecoxib
1
Acupuncture Therapy
1
26S proteasome non-ATPase regulatory subunit 13
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Head and Neck Neoplasms
×
DMAC2L protein, human
×
Clear all
NCT02748707
2022-04-28
ERLO-XIB
Tata Memorial Hospital
Phase 2
Unknown
64 enrolled